scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12032-014-0867-X |
P8608 | Fatcat ID | release_t3kod2tonvdudbyvj6fy72tdju |
P698 | PubMed publication ID | 24488617 |
P5875 | ResearchGate publication ID | 260041149 |
P50 | author | Lidija Todorovic | Q86216137 |
Boban Stanojevic | Q48027092 | ||
Nina Petrovic | Q58023844 | ||
Vesna Mandusic | Q59199703 | ||
P2093 | author name string | Bogomir Dimitrijević | |
Jelena Roganović | |||
Silvana Lukić | |||
P2860 | cites work | Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland | Q73135577 |
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1 | Q79643431 | ||
Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients | Q95393010 | ||
MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody | Q28142514 | ||
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
miR-21-mediated tumor growth | Q29616149 | ||
microRNA, cell cycle, and human breast cancer | Q33703585 | ||
MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression | Q33784804 | ||
Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer. | Q33834430 | ||
Expression profile of mammalian microRNAs in endometrioid adenocarcinoma | Q34902744 | ||
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC | Q35570987 | ||
Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome | Q35605873 | ||
Classification of ductal carcinoma in situ by gene expression profiling | Q35605885 | ||
Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast | Q35713817 | ||
The role of microRNAs in breast cancer migration, invasion and metastasis | Q36396579 | ||
Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer | Q36546638 | ||
Genetic heterogeneity of breast cancer metastasis may be related to miR-21 regulation of TIMP-3 in translation | Q37045230 | ||
Micromanagers of malignancy: role of microRNAs in regulating metastasis | Q37233362 | ||
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations | Q37388937 | ||
MicroRNA function in cancer: oncogene or a tumor suppressor? | Q37655612 | ||
Regulation and function of miRNA-21 in health and disease. | Q37895431 | ||
MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach | Q39878140 | ||
Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration | Q40407110 | ||
Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. | Q44850177 | ||
Epigenetics and microRNAs | Q46057707 | ||
Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma. | Q50603014 | ||
Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). | Q52553751 | ||
Genetic pathways in the evolution of breast ductal carcinoma in situ | Q57006156 | ||
P433 | issue | 3 | |
P921 | main subject | tumor invasion | Q60750433 |
P304 | page(s) | 867 | |
P577 | publication date | 2014-02-02 | |
P1433 | published in | Medical Oncology | Q2152666 |
P1476 | title | The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion | |
P478 | volume | 31 |
Q37022250 | Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor |
Q48030886 | Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels |
Q33820667 | Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor |
Q38987650 | Expression and clinicopathological significance of microRNA-21 and programmed cell death 4 in malignant melanoma |
Q64970233 | Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma. |
Q35247522 | Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker |
Q54356219 | Higher miR-21 expression in invasive breast carcinomas is associated with positive estrogen and progesterone receptor status in patients from Serbia. |
Q39377639 | Levels of MicroRNA Heterogeneity in Cancer Biology. |
Q33364654 | MicroRNA in breast cancer: The association with BRCA1/2. |
Q48146192 | MicroRNA-21 antisense oligonucleotide improves the sensitivity of A375 human melanoma cell to Cisplatin: An in vitro study |
Q36089730 | MicroRNA‑21 regulates the expression of BTG2 in HepG2 liver cancer cells |
Q60958994 | Non-Coding RNAs in Breast Cancer: Intracellular and Intercellular Communication |
Q90183453 | Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis |
Q38849205 | Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. |
Q39581773 | Transcriptome Analysis of Cultured Limbal Epithelial Cells on an Intact Amniotic Membrane following Hypothermic Storage in Optisol-GS. |
Q38739495 | miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development. |
Q35113386 | miRNA - Therapeutic tool in breast cancer? Where are we now? |
Q57106025 | microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy |
Q38336073 | microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer |
Search more.